Lacerta Bio was co-founded in 2010 by Carlos N. Velez, Ph.D., MBA. He has 20 years experience in pharmaceutical research, consulting, venture capital, entrepreneurship, and business development. Current and past clients include Troikaa (India), KRICT (South Korea), Cornerstone (USA), Almac (UK), University of Bath (UK), and others.
Prior to Lacerta Bio, Carlos was the Director of Business Development and Licensing for Penwest Pharmaceuticals, a leading oral controlled release drug delivery company. His previous consulting clients span from start up biotechnology companies to large companies such as Forest Laboratories and Pfizer, plus venture capital and private equity firms.
He began his career as a Consultant, then Senior Consultant with The Frankel Group (now Huron Consulting), a leading boutique life science management consultancy.
He holds an MBA from the Rochester Institute of Technology, a Ph.D. from the University of North Carolina at Chapel Hill, and a BS from the Albany College of Pharmacy.